Medtronic PLC (MDT)vsPenumbra Inc (PEN)
MDT
Medtronic PLC
$87.89
+1.51%
HEALTHCARE · Cap: $110.62B
PEN
Penumbra Inc
$336.27
+0.63%
HEALTHCARE · Cap: $13.11B
Smart Verdict
WallStSmart Research — data-driven comparison
Medtronic PLC generates 2428% more annual revenue ($35.48B vs $1.40B). MDT leads profitability with a 13.0% profit margin vs 12.7%. PEN appears more attractively valued with a PEG of 0.76. PEN earns a higher WallStSmart Score of 64/100 (C+).
MDT
Buy56
out of 100
Grade: C
PEN
Buy64
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-255.7%
Fair Value
$24.34
Current Price
$87.89
$63.55 premium
Margin of Safety
-60.3%
Fair Value
$211.07
Current Price
$336.27
$125.20 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Reasonable price relative to book value
Strong operational efficiency at 20.0%
Generating 2.3B in free cash flow
Safe zone — low bankruptcy risk
Growing faster than its price suggests
Revenue surging 22.1% year-over-year
Earnings expanding 38.3% YoY
Areas to Watch
Earnings declined 11.8%
Trading at 9.2x book value
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : MDT
The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.
Bull Case : PEN
The strongest argument for PEN centers on Altman Z-Score, PEG Ratio, Revenue Growth. Revenue growth of 22.1% demonstrates continued momentum. PEG of 0.76 suggests the stock is reasonably priced for its growth.
Bear Case : MDT
The primary concerns for MDT are EPS Growth.
Bear Case : PEN
The primary concerns for PEN are Price/Book, P/E Ratio. A P/E of 74.1x leaves little room for execution misses.
Key Dynamics to Monitor
MDT profiles as a value stock while PEN is a growth play — different risk/reward profiles.
PEN carries more volatility with a beta of 0.84 — expect wider price swings.
PEN is growing revenue faster at 22.1% — sustainability is the question.
MDT generates stronger free cash flow (2.3B), providing more financial flexibility.
Bottom Line
PEN scores higher overall (64/100 vs 56/100) and 22.1% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Medtronic PLC
HEALTHCARE · MEDICAL DEVICES · USA
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
Penumbra Inc
HEALTHCARE · MEDICAL DEVICES · USA
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally. The company is headquartered in Alameda, California.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?